AC610 is a automatic 5-part hematology analyzer with compact size and advanced design targeting the small and middle size diagnostic labs, hospitals and clinics market, with lower running cost, more user-friendly operation and cost effective budget.
Principles : Tri-angle Laser scatter Flow Cytometry method 3D Scattergram analysis Impedance method for RBC and PLT counting Cyanide free reagent for HGB test Parameters : WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW-SD, RDW-CV, PLT, MPV, PCT, PDW, P-LCR, P-LCC, NEU%, LYM%, MON%, EOS%, BAS%, NEU#, LYM#, MON#, EOS#, BAS# 1 3D Scattergram 3 Histograms(WBC/BASO, RBC, PLT) 4 Research parameter : ALY%, ALY#, LIC%, LIC# Test Mode : CBC mode, CBC+DIFF mode Venous whole blood,Capillary whole blood and Prediluted Throughput : 60 tests/hour Sample Volume : CBC+DIFF mode:≤20ul & CBC mode:≤10ul Data Memory : Up to 100,000 results(including histogram, scarttergram, patient information) Display : 14 inch touch screen, resolution 1366*768 Interface : 1 LAN port, 4 USB ports Communication : Support HL7 protocal/LIS & Internal RFID reader Printout : Support various external USB printers, printout formats user definable Size : L * W * H = 480*375*517(mm) Weight : 36 kg
More From Clinical Laboratory Analyzer & Equipment
AC310 is a automatic 3-part hematology analyzer with compact size and advanced design targeting the small and middle size diagnostic labs, hospitals and clinics market, with lower running cost, more user-friendly operation and cost effective budget.
AC610 is a automatic 5-part hematology analyzer with compact size and advanced design targeting the small and middle size diagnostic labs, hospitals and clinics market, with lower running cost, more user-friendly operation and cost effective budget.
The fully automated H8 Hemoglobin Analyzer reports HbA1c result in 130 seconds with Hb variants recognization, providing the outstanding solution for quick and reliable diabetic monitoring. No sample preparation and walk-away operation. Samples with Hb variants can be in depth analyzed under β-Thalassemia program.